Novo Nordisk A/S (NVO)
Symbol Info
Listed Symbol NVO
Name Novo Nordisk A/S
Share Info
Annual Info
Latest Fiscal Dividend Per Share $1.20
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $35,431,059,580
Latest Fiscal EPS $2.45
Price Info
21 Day Moving Average $51.4152
21 Day EMA $51.396860
50 Day Moving Average $51.1840
50 Day EMA $51.029290
200 Day EMA $49.288500
200 Day Moving Average 49.131040
52 Week High $53.55
52 Week Low $41.59
52 Week Change $26.310400
Alpha 0.001719
Beta 0.5958
Standard Deviation 0.065166
R2 0.098676
Periods 60
Share Information
10 Day Average Volume 1,312,169
20 Day Average Volume 1,408,016
30 Day Average Volume 1,465,779
50 Day Average Volume 1,443,077
Outstanding Shares 2,364,853,006
Float Shares 2,364,853,006
Percent Float 100.00%
Short Interest 5,789,426
Short Percent Float 0.20%
Short Interest Ratio 3.97
Short Date 2019-09-13
Holders
Institutions 829
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 9,558,201
Institute Holdings Percent 8.400000
Institute Sold Previous 3 Months 9,374,362
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-0.0900002
7 Day Percent Change -0.18%
21 Day Price Change $-1.7099991
21 Day Percent Change -3.23%
30 Day Price Change $0.3899994
30 Day Percent Change 0.77%
Month To Date Price Change $-0.47
Month To Date Percent -0.91%
90 Day Price Change $2.723511
90 Day Percent Change 5.61%
Quarter To Date $-0.470001
Quarter To Date Percent -0.91%
180 Day Price Change $0.770962
180 Day Percent Change 1.53%
200 Day Price Change $0.126717
200 Day Percent Change 0.25%
Year To Date $6.248177
Year To Date Percent 13.89%
Profile
Description With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Details
Issue Type CS
Market Cap $121,151,419,497
Sec Type DR
Auditor PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Total Shares Outstanding 2,364,853,006
CEO
Employees 42,154
Last Audit UQ
Classification
CIK 0000353278
Industry Biotechnology
Sector Healthcare
NAICS
Info
Address Novo Alle
Bagsvaerd, 2880
Website http://www.novonordisk.com
Facisimile
Telephone +45 44448888
Email phak@novonordisk.com
Key Ratios
Profitability
EBIT Margin 41.50
EBITDA Margin 45.5
Pre-Tax Profit Margin 41.5
Profit Margin Cont 13.56
Gross Margin 84.00
Profit Margin TOT 13.56
Income Statements
Revenue $31,695,516,900
Revenue Per Share $87.9247
Revenue 3 Years $14.96
Revenue 5 Years $11.88
Valuation Measures
PE Ratio 21.10
Enterprise Value $120,537,653,244
Price To Sales 0.582658
Price To Free Cash 76.800000
PE High Last 5 Years 36.9
Price To Book 15.2
Price To Cash Flow 18.7
PE Low Last 5 Years 15.5
Price To Tangible Book 14.6
Financial Strength
Total Debt To Equity 0.1
Int Coverage 29.3
Current Ratio 1.0
Leverage Ratio 2.3
Quick Ratio 0.7
Long Term Debt To Capital 0.05
Assets
Receivables Turnover 8.0
Invoice Turnover 1.10
Assets Turnover 1.80
Management Effectiveness
Return Assets 33.52
Return On Equity 72.54
Return On Capital 73.98
Dividends
Dividend 3 Years $2.70
Dividend 5 Years $10.55
Ex Dividend Date 2019-08-16 00:00:00.0
Dividend Rate $0.90
Dividend Yield 1.75%
Payment Type Cash
Your Recent History
NYSE
NVO
Novo Nordi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20191019 05:34:52